Diabetic ketoacidosis risk during the COVID-19 pandemic
- PMID: 34481553
- PMCID: PMC8412797
- DOI: 10.1016/S2213-8587(21)00241-2
Diabetic ketoacidosis risk during the COVID-19 pandemic
Conflict of interest statement
PV reports grants from the National Institutes of Health (K23DK DK113241-A1); personal fees from Boehringer Ingelheim, and consultancy fees from Takeda Pharmaceuticals. GEU declares no competing interests.
Comment on
-
Temporal trends in emergency admissions for diabetic ketoacidosis in people with diabetes in England before and during the COVID-19 pandemic: a population-based study.Lancet Diabetes Endocrinol. 2021 Oct;9(10):671-680. doi: 10.1016/S2213-8587(21)00208-4. Epub 2021 Sep 2. Lancet Diabetes Endocrinol. 2021. PMID: 34481558 Free PMC article.
References
-
- Dhatariya KK, Glaser NS, Codner E, Umpierrez GE. Diabetic ketoacidosis. Nat Rev Dis Primers. 2020;6:40. - PubMed
-
- Misra S, Barron E, Vamos E, et al. Temporal trends in emergency admissions for diabetic ketoacidosis in people with diabetes in England before and during the COVID-19 pandemic: a population-based study. Lancet Diabetes Endocrinol. 2021 doi: 10.1016/S2213-8587(21)00208-4. published online Sept 2. - DOI - PMC - PubMed
-
- Zhong VW, Juhaeri J, Mayer-Davis EJ. Trends in hospital admission for diabetic ketoacidosis in adults with type 1 and type 2 diabetes in England, 1998–2013: a retrospective cohort study. Diabetes Care. 2018;41:1870–1877. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
